John Turman Fleming Sells 500 Shares of USANA Health Sciences, Inc. (NYSE:USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director John Turman Fleming sold 500 shares of the stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $33.30, for a total transaction of $16,650.00. Following the completion of the sale, the director now directly owns 4,026 shares in the company, valued at $134,065.80. This trade represents a 11.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

USANA Health Sciences Stock Down 1.9 %

Shares of USNA stock opened at $32.49 on Thursday. The firm has a market cap of $619.32 million, a price-to-earnings ratio of 11.48, a PEG ratio of 0.93 and a beta of 0.98. USANA Health Sciences, Inc. has a 52-week low of $27.71 and a 52-week high of $50.32. The company’s 50 day moving average is $32.86 and its 200 day moving average is $36.08.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.15. The company had revenue of $213.61 million during the quarter, compared to the consensus estimate of $208.82 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. Analysts anticipate that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Institutional Investors Weigh In On USANA Health Sciences

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Public Employees Retirement System of Ohio lifted its stake in shares of USANA Health Sciences by 635.5% during the fourth quarter. Public Employees Retirement System of Ohio now owns 5,075 shares of the company’s stock worth $182,000 after buying an additional 4,385 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of USANA Health Sciences by 83.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 17,300 shares of the company’s stock worth $621,000 after buying an additional 7,877 shares during the period. Millennium Management LLC acquired a new stake in shares of USANA Health Sciences during the fourth quarter worth $633,000. Lazard Asset Management LLC lifted its stake in shares of USANA Health Sciences by 24,765.5% during the fourth quarter. Lazard Asset Management LLC now owns 7,211 shares of the company’s stock worth $258,000 after buying an additional 7,182 shares during the period. Finally, Jacobs Levy Equity Management Inc. lifted its stake in shares of USANA Health Sciences by 16.7% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 128,976 shares of the company’s stock worth $4,629,000 after buying an additional 18,490 shares during the period. 54.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on USNA. Sidoti lowered shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th. StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Finally, DA Davidson reduced their target price on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a research report on Thursday, February 27th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.